Horizon Therapeutics Public Ltd Co

MARSHALL WACE, LLP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

674,698

Value ($000)

78,056

Weight

0.2%

2020 Q2 - 2023 Q3 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	78,056	0.2%	674,698	9/30/2023
2023 Q2	8/14/2023	63,995	0.1%	622,214	6/30/2023
2023 Q1	5/15/2023	43,691	0.1%	400,321	3/31/2023
2022 Q4	2/14/2023	53,178	0.1%	467,291	12/31/2022
2022 Q3	11/14/2022	155,118	0.4%	2,506,329	9/30/2022
2022 Q2	8/15/2022	12,640	0.0%	158,495	6/30/2022
2022 Q1	5/16/2022	69,239	0.1%	658,106	3/31/2022
2021 Q4	2/14/2022	178,522	0.4%	1,656,679	12/31/2021
2021 Q3	11/15/2021	4,674	0.0%	42,669	9/30/2021
2021 Q1	5/17/2021	285	0.0%	3,097	3/31/2021
2020 Q4	2/16/2021	5,531	0.0%	75,619	12/31/2020
2020 Q3	11/16/2020	772	0.0%	9,935	9/30/2020
2020 Q2	8/13/2020	6,350	0.0%	114,242	6/30/2020